BIO-key International (NASDAQ:BKYI – Get Rating) last issued its quarterly earnings data on Tuesday, March 29th. The technology company reported ($0.26) earnings per share (EPS) for the quarter. BIO-key International had a negative net margin of 96.70% and a negative return on equity of 27.76%. The company had revenue of $0.94 million during the quarter.
Shares of NASDAQ:BKYI traded down $0.01 on Wednesday, hitting $2.08. The company had a trading volume of 10,596 shares, compared to its average volume of 71,736. BIO-key International has a 52-week low of $1.90 and a 52-week high of $4.28. The business has a 50 day moving average of $2.25 and a 200 day moving average of $2.36. The company has a market cap of $17.48 million, a PE ratio of -3.30 and a beta of 0.86.
BIO-key International Company Profile (Get Rating)
BIO-key International, Inc develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform.
- Get a free copy of the StockNews.com research report on BIO-key International (BKYI)
- Can Six Flags(SIX) or Cedar Fair (FUN) Give Investors a Thrill Later This Year?
- Beyond Meat Could Sizzle After Q1 Results Are Released
- Is Now The Time To Buy Coinbase (NASDAQ: COIN)?
- Inflation Hasn’t Peaked At Reynolds Consumer Products
- Fifth Third Bancorp Stock Bestows Opportunity
Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.